# 2026-22484: DEA Clarifies That Renewal Applications Follow the Same Amendment Rules

2026-22484, Technical Amendment to the Regulation Regarding Amendments to Applications, is a Federal Register rule from Justice Department, Drug Enforcement Administration published 2026-11-04, effective 2026-11-04 (as of 2026-11-04).

- Canonical: https://policyrisk.com/federal-register/2026-22484
- As of: 2026-11-04
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-22484
- Title: Technical Amendment to the Regulation Regarding Amendments to Applications
- Type: Rule
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 69500
- Published: 2026-11-04
- Effective: 2026-11-04
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: 1117-ZA09
- Last updated: 2026-11-04

## In one line

DEA Clarifies That Renewal Applications Follow the Same Amendment Rules

## Summary

The Drug Enforcement Administration updated its rules to make clear that the same process for changing or withdrawing new registration applications also applies to renewal applications. This change doesn’t affect any fees or deadlines but just clears up confusion. It takes effect immediately on November 4, 2026, and affects anyone renewing or applying for DEA registration.

## Abstract

This final rule updates a Drug Enforcement Administration regulation to clarify that the provision regarding amendments to and withdrawal of registration applications also applies to applications for registration renewal. This action makes no substantive changes to this regulation.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22288](https://policyrisk.com/federal-register/2026-22288): Importer of Controlled Substances Application: Globyz Pharma LLC, 2026-11-02
- [2026-22289](https://policyrisk.com/federal-register/2026-22289): Bulk Manufacturer of Controlled Substances Application: AJNA Biosciences, 2026-11-02

## Sources
- [2026-22484 on federalregister.gov](https://www.federalregister.gov/documents/2026/11/04/2026-22484/technical-amendment-to-the-regulation-regarding-amendments-to-applications)
- [2026-22484 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-11-04/pdf/2026-22484.pdf)

## Related
- [Previous: 2026-22478, Safety Zone; Lake Michigan, Chicago, IL](https://policyrisk.com/federal-register/2026-22478)
- [Next: 2026-22497, Amendment of Domestic Very High Frequency Omnidirectional Range (VOR) Federal A…](https://policyrisk.com/federal-register/2026-22497)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-22484 (as of 2026-11-04).